BACKGROUND: Biological complexity leads to significant variation in the survival of patients with stage I non-small-cell lung cancer (NSCLC). DNA damage response (DDR) pathways play a critical role in maintaining genomic stability and in the progression of NSCLC. Therefore, the development of a prognostic biomarker focusing on DDR pathways is an intriguing issue. PATIENTS AND METHODS: Expression of several proteins (ATM, ATMpS1981, γH2AX, 53BP1, 53BP1pS25, Chk2, Chk2pT68, MDC1, MDC1pS964, BRCA1pS1423, and ERCC1) and overall survival were investigated in 889 pathological stage I NSCLC patients. RESULTS: Low expression of BRCA1pS1423 or ERCC1 was significantly associated with worse survival in the whole cohort of patients. Analysis performed based on histology revealed that low expression of γH2AX, Chk2pT68, or ERCC1 was a poor prognostic factor in squamous cell carcinoma patients [adjusted hazard ratio (aHR), Cox P: 1.544, 0.012 for γH2AX; 1.624, 0.010 for Chk2pT68; 1.569, 0.011 for ERCC1]. The analysis of the interaction between two proteins showed that this effect was more pronounced in squamous cell carcinoma patients. However, these effects were not detected in adenocarcinoma patients. CONCLUSIONS: The proteins involved in DDR pathways exhibited differential expression between squamous cell carcinoma and adenocarcinoma and were important determinants of survival in stage I squamous cell carcinoma patients.
BACKGROUND: Biological complexity leads to significant variation in the survival of patients with stage I non-small-cell lung cancer (NSCLC). DNA damage response (DDR) pathways play a critical role in maintaining genomic stability and in the progression of NSCLC. Therefore, the development of a prognostic biomarker focusing on DDR pathways is an intriguing issue. PATIENTS AND METHODS: Expression of several proteins (ATM, ATMpS1981, γH2AX, 53BP1, 53BP1pS25, Chk2, Chk2pT68, MDC1, MDC1pS964, BRCA1pS1423, and ERCC1) and overall survival were investigated in 889 pathological stage I NSCLCpatients. RESULTS: Low expression of BRCA1pS1423 or ERCC1 was significantly associated with worse survival in the whole cohort of patients. Analysis performed based on histology revealed that low expression of γH2AX, Chk2pT68, or ERCC1 was a poor prognostic factor in squamous cell carcinomapatients [adjusted hazard ratio (aHR), Cox P: 1.544, 0.012 for γH2AX; 1.624, 0.010 for Chk2pT68; 1.569, 0.011 for ERCC1]. The analysis of the interaction between two proteins showed that this effect was more pronounced in squamous cell carcinomapatients. However, these effects were not detected in adenocarcinomapatients. CONCLUSIONS: The proteins involved in DDR pathways exhibited differential expression between squamous cell carcinoma and adenocarcinoma and were important determinants of survival in stage I squamous cell carcinomapatients.
Authors: Swapnajit Chakravarty; Wei-Cheng Lai; Yi Zou; Harry A Drabkin; Robert M Gemmill; George R Simon; Steve H Chin; Ray T Chen Journal: Biosens Bioelectron Date: 2012-11-27 Impact factor: 10.618
Authors: Matthias Villalobos; Piotr Czapiewski; Niels Reinmuth; Jürgen R Fischer; Stefan Andreas; Cornelius Kortsik; Monika Serke; Martin Wolf; Petra Neuser; Alexander Reuss; Philipp A Schnabel; Michael Thomas Journal: Med Oncol Date: 2018-06-15 Impact factor: 3.064
Authors: Eszter Podmaniczky; Katalin Fábián; Judit Pápay; Rita Puskás; Márton Gyulai; József Furák; László Tiszlavicz; György Losonczy; József Tímár; Judit Moldvay Journal: Pathol Oncol Res Date: 2014-09-07 Impact factor: 3.201
Authors: Luc Friboulet; Ken André Olaussen; Jean-Pierre Pignon; Frances A Shepherd; Ming-Sound Tsao; Stephen Graziano; Robert Kratzke; Jean-Yves Douillard; Lesley Seymour; Robert Pirker; Martin Filipits; Fabrice André; Eric Solary; Florence Ponsonnailles; Angélique Robin; Annabelle Stoclin; Nicolas Dorvault; Frédéric Commo; Julien Adam; Elsa Vanhecke; Patrick Saulnier; Jürgen Thomale; Thierry Le Chevalier; Ariane Dunant; Vanessa Rousseau; Gwénaël Le Teuff; Elisabeth Brambilla; Jean-Charles Soria Journal: N Engl J Med Date: 2013-03-21 Impact factor: 91.245
Authors: Daniel Richard Gomez; Lauren Averett Byers; Monique Nilsson; Lixia Diao; Jing Wang; Lerong Li; Pan Tong; Mia Hofstad; Babita Saigal; Ignacio Wistuba; Neda Kalhor; Stephen Swisher; Youhong Fan; Waun Ki Hong; Milind Suraokar; Carmen Behrens; Cesar Moran; John Victor Heymach Journal: Oncotarget Date: 2018-01-30
Authors: Thorsten Derlin; Natalia Bogdanova; Fiona Ohlendorf; Dhanya Ramachandran; Rudolf A Werner; Tobias L Ross; Hans Christiansen; Frank M Bengel; Christoph Henkenberens Journal: Cancers (Basel) Date: 2021-03-25 Impact factor: 6.639